2012
DOI: 10.1002/cbf.2921
|View full text |Cite
|
Sign up to set email alerts
|

E‐ADA activity in lymphocytes of an experimental model of pythiosis treated with immunotherapy

Abstract: Pythiosis is a life-threatening disease caused by the oomycete Pythium insidiosum. Some authors have suggested the involvement of a Th2-like immune response in the infected host, which leads to extensive tissue damage. The switch from a Th2 to a Th1 response pattern is one hypothesis to explain the curative properties of immunotherapy. Taking into account the importance of immunotherapy for pythiosis treatment and the contribution of adenine nucleotides in the immunoregulation of the host, we evaluated the ect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
9
0
1

Year Published

2015
2015
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 23 publications
3
9
0
1
Order By: Relevance
“…3C). In support to our findings, a decreased lymphocyte ecto-ADA activity has been previously reported in rabbits with pythiosis, an effect that was also reversed by immunotherapy [3]. Our data also extend previous observations showing that 1) deferasirox treatment enhanced the host inflammatory response to mucormycosis [11], and 2) ADA therapy is able to increase the secretion of Th-1 pro-inflammatory cytokines, enhancing allogeneic T-cell proliferation and immunogenicity [6].…”
Section: Discussionsupporting
confidence: 92%
See 3 more Smart Citations
“…3C). In support to our findings, a decreased lymphocyte ecto-ADA activity has been previously reported in rabbits with pythiosis, an effect that was also reversed by immunotherapy [3]. Our data also extend previous observations showing that 1) deferasirox treatment enhanced the host inflammatory response to mucormycosis [11], and 2) ADA therapy is able to increase the secretion of Th-1 pro-inflammatory cytokines, enhancing allogeneic T-cell proliferation and immunogenicity [6].…”
Section: Discussionsupporting
confidence: 92%
“…The elevated iron availability also impairs host immune responses, as observed in patients with thalassemia or hemochromatosis, which frequently have reduced CD8+ T-cell counts that respond positively to iron chelation therapy [7]. Current evidence shows that the mechanisms of cure of the immunotherapeutic treatment against pythiosis are based on the switch from a Th2 (eosinophils) to a Th1 (macrophages and lymphocytes) subset [3]. Therefore, the impact of deferasirox in modulating the immune response was compared to immunotherapy by histopathological analysis and by measuring ADA activity in the lesions of rabbits with experimental pythiosis.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…It was later found in successfully treated mammals that in addition to the switching from an eosinophilic to a mononuclear cell response, a shift from a Th2 to a Th1 cytokine profile occurred [2]. Moreover, when this hypothesis was tested in the experimental rabbit model, a similar profile was found with the expression of lymphocytic NTPDase [15] and ecto-adenosine deaminase [16], also pointing to a Th2 down-regulation.…”
Section: Introductionmentioning
confidence: 86%